uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$9.17
+0.0550 ( +0.60% ) 268.3K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$9.17

Previous close


$9.11

Volume


268.3K

Market cap


$439.86M

Day range


$8.92 - $9.41

52 week range


$3.73 - $11.35

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 12, 2023

Latest News